CoChat

Creatine for the Treatment of Depression

Open access

The DOI matches its Crossref record; 193 of the 194 references it cites were found in a registry or an index.

Abstract

Depressed mood, which can occur in the context of major depressive disorder, bipolar disorder, and other conditions, represents a serious threat to public health and wellness. Conventional treatments are not effective for a significant proportion of patients and interventions that are often beneficial for treatment-refractory depression are not widely available. There is, therefore, an immense need to identify novel antidepressant strategies, particularly strategies that target physiological pathways that are distinct from those addressed by conventional treatments. There is growing evidence from human neuroimaging, genetics, epidemiology, and animal studies that disruptions in brain energy production, storage, and utilization are implicated in the development and maintenance of depression. Creatine, a widely available nutritional supplement, has the potential to improve these disruptions in some patients, and early clinical trials indicate that it may have efficacy as an antidepressant agent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom9090406

Cites

193 of 193 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Example phosphorus 31 magnetic resonance spectrum from the frontal lobes of a single subject. Abbreviations: PCr: phosphocreatine; α/β/γ-NTP: α/β/γ-nucleoside triphosphate; PME: phosphomonoester; PDE: phosphodiester; Pi: inorganic phosphate.
Figure 1 Example phosphorus 31 magnetic resonance spectrum from the frontal lobes of a single subject. Abbreviations: PCr: phosphocreatine; α/β/γ-NTP: α/β/γ-nucleoside triphosphate; PME: phosphomonoester; PDE: phosphodiester; Pi: inorganic phosphate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 193 references

Research works printed but not linked: 3

  1. Costentin, 2003, Adenosine A2A receptors and depression, Neurology, 61, S82
  2. Cheng, 2002, Moderate altitude increases suicide deaths, Ann. Emerg. Med., 40, S55
  3. Renshaw, P.F., Prescot, A., Ongur, D., Huber, R., and Yurgelun-Todd, D. (2012, January 19–22). Suicide and brain chemical changes with altitude. Proceedings of the 6th Biennial Congress of The International Society of Affective Disorders, London, UK.

Cited by

See all 74

Metadata

Authors
Kious, B. M., Kondo, D. G., & Renshaw, P. F.
Affiliations
University of Utah (US)
Corresponding author
Kious, Brent M.
Venue
Biomolecules
Publisher
MDPI AG
Published
2019-08-23
Volume
9
Issue
9
Pages
406
ISSN
2218-273X (ISSN-L)
OpenAlex
W2969637735
Cited by
74
References
194
Citations by year
2026: 11 · 2025: 14 · 2024: 15 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 9
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Brain and Behavior Research Foundation (NARSAD Young Investigator Grant)
  • U.S. Department of Veterans Affairs (I01-CX000812, I01-CX001611)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
creatine, depression, antidepressant treatment, treatment-resistant depression, brain energy metabolism, major depressive disorder, bipolar disorder, dietary supplements
MeSH terms
Clinical Studies as Topic, Animals, Bipolar Disorder, Brain, Creatine, Major Depressive Disorder, Energy Metabolism, Humans, Phosphocreatine, Nutritional Support

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Creatine for the Treatment of Depression. https://app.cochat.ai/papers/10.3390/biom9090406
The paper
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019). Creatine for the Treatment of Depression. Biomolecules. https://doi.org/10.3390/biom9090406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.